Insilico Medicine � KAT6 Inhibitor (Breast Cancer treatment)

This drug is a small molecule inhibitor of KAT6, a histone acetyltransferase (“HAT”) that is dysregulated in several cancers, including breast, lung, and ovarian cancers. The drug aims to inhibit KAT6, blocking ERα at the transcriptional level, which could be beneficial in the treatment of ER+/HER2- breast cancer.